What is SAGT's health score?

SAGTEC GLOBAL Ltd (SAGT) has a TradeApes health score of 64 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is SAGT's estimated fair value?

Based on our 5-year discounted cash flow model, SAGTEC GLOBAL Ltd's estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is SAGT undervalued or overvalued?

Our model currently rates SAGT as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for SAGT... Refresh in a moment for the full analysis.

SAGTEC GLOBAL Ltd (SAGT)

Technology Inconclusive inconclusive healthy

$0.95

Updated: 2026-06-06

TradeApes Score

Financial Strength

85 Strong

Operating Trend

50 Mixed

Relative Value

50 Mixed

Capital Allocation

65 Healthy

Risk

80 Strong

Key Findings

+ Low leverage — net debt/EBITDA below 1×

Unlock Full Report →

− Sharp revenue decline — sales down more than 15% year over year

Unlock Full Report →

1 free score card remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.